Clinical Trial Update: The OPTIMA-5 Trail [Phase 4]

View source ↗

Summary

Phase 4 trial update for OPTIMA-5 Trial completed, focusing on Acute Myocardial Infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Acute Myocardial Infarction | Phase 4 | Status: COMPLETED